23andMe weighs a sale as cash dwindles
Embattled genetics testing giant 23andMe is thinking of selling itself as it runs out of cash.
The company needs to raise more money to continue …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
